Evidence map›Paper›PMID 27091969›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Clusters of circulating tumor cells traverse capillary-sized vessels.

Sam H Au, Brian D Storey, John C Moore, Qin Tang, Yeng-Long Chen, Sarah Javaid, A Fatih Sarioglu, Ryan Sullivan, Marissa W Madden, Ryan O'Keefe and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 262 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
262citing papers in PubMed, 2 pooled it
28.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

262 citing papers in PubMed, 2 syntheses or guidelines pooled it, 491 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. CTC cluster in breast cancer: synergetic metastasis promotion mechanism and transformation path from platelet cloaking to leukocyte escort.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  10. A Novel Zebrafish Liver-Specific Metastasis Model Reveals c-Met as a Driver of Liver Tropism.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Microphysiological systems for metastasis research: a stepwise approach.Cellular oncology (Dordrecht, Netherlands) · 2025
    Review
  18. Article
  19. Review
  20. Review

202 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Sam H AuCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114;
Brian D StoreyOlin College, Needham, MA 02492;
John C MooreMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129; Department of Molecular Pathology and Regenerative Medicine, Massachusetts General Hospital, Charlestown, MA 02129; Harvard Stem Cell Institute, Cambridge, MA 02138;
Qin TangMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129; Department of Molecular Pathology and Regenerative Medicine, Massachusetts General Hospital, Charlestown, MA 02129; Harvard Stem Cell Institute, Cambridge, MA 02138;
Yeng-Long ChenInstitute of Physics, Academia Sinica, Taipei 11529, Taiwan;
Sarah JavaidMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114;
A Fatih SariogluCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114;
Ryan SullivanMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114;
Marissa W MaddenMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129;
Ryan O'KeefeMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129;
Daniel A HaberMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; Howard Hughes Medical Institute, Bethesda, MD 20815;
Shyamala MaheswaranDepartment of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129;
David M LangenauMassachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129; Department of Molecular Pathology and Regenerative Medicine, Massachusetts General Hospital, Charlestown, MA 02129; Harvard Stem Cell Institute, Cambridge, MA 02138;
Shannon L StottCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; mehmet_toner@hms.harvard.edu sstott@mgh.harvard.edu.
Mehmet TonerCenter for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; Shriners Hospital for Children, Boston, MA 02114 mehmet_toner@hms.harvard.edu sstott@mgh.harvard.edu.
Harvard University · USMassachusetts General Hospital · USFranklin W. Olin College of Engineering · USInstitute of Physics, Academia Sinica · TWShriners Hospitals for Children - Boston · US

Funding

Point-of care Microfluidics for Early Detection of CancerU01EB012493 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI HABER, DANIEL A., TONER, MEHMET · 2010 to 2018
$19.6M
Bio-MicroElectroMechanical Systems Resource CenterP41EB002503 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI TONER, MEHMET · 2004 to 2018
$17.4M
Immune Compromises Zebrafish for Cell TransplantationR24OD016761 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI LANGENAU, DAVID MICHAEL · 2013 to 2021
$5.2M
Isolating clinically important cells from large fluid volumes with microfluidicsF33GM109574 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI STOREY, BRIAN · 2014 to 2014
$40k
NIBIB NIH HHS P41 EB002503NIBIB NIH HHS U01 EB012493NIGMS NIH HHS F33 GM109574NIH HHS R24 OD016761
6 · The paper itself

Abstract

Multicellular aggregates of circulating tumor cells (CTC clusters) are potent initiators of distant organ metastasis. However, it is currently assumed that CTC clusters are too large to pass through narrow vessels to reach these organs. Here, we present evidence that challenges this assumption through the use of microfluidic devices designed to mimic human capillary constrictions and CTC clusters obtained from patient and cancer cell origins. Over 90% of clusters containing up to 20 cells successfully traversed 5- to 10-μm constrictions even in whole blood. Clusters rapidly and reversibly reorganized into single-file chain-like geometries that substantially reduced their hydrodynamic resistances. Xenotransplantation of human CTC clusters into zebrafish showed similar reorganization and transit through capillary-sized vessels in vivo. Preliminary experiments demonstrated that clusters could be disrupted during transit using drugs that affected cellular interaction energies. These findings suggest that CTC clusters may contribute a greater role to tumor dissemination than previously believed and may point to strategies for combating CTC cluster-initiated metastasis.

Indexed as

Cell MovementNeoplastic Cells, CirculatingCapillariesHumanscancer metastasiscapillary microhemodynamicscirculating tumor cell cluster microemboliCTC clustersmicrofluidics

Identifiers

PMID27091969
PMCPMC4983862
OpenAlexW2336248112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.